Persistent Inflammation Subverts Thrombospondin-1–Induced Regulation of Retinal Angiogenesis and Is Driven by CCR2 Ligation

The American Journal of Pathology - Tập 180 - Trang 235-245 - 2012
Mei Chen1, David A. Copland2, Jiawu Zhao1, Jian Liu2, John V. Forrester3, Andrew D. Dick2, Heping Xu1,3
1Centre for Vision and Vascular Science, Queen's University Belfast, Belfast, United Kingdom
2School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom
3Section of Immunology and Infection, Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom

Tài liệu tham khảo

Coleman, 2008, Age-related macular degeneration, Lancet, 372, 1835, 10.1016/S0140-6736(08)61759-6 Dhingra, 2010, Inflammatory choroidal neovascular membrane in posterior uveitis—pathogenesis and treatment, Indian J Ophthalmol, 58, 3, 10.4103/0301-4738.58467 Yannuzzi, 2001, Retinal angiomatous proliferation in age-related macular degeneration, Retina, 21, 416, 10.1097/00006982-200110000-00003 Klein, 2004, The epidemiology of age-related macular degeneration, Am J Ophthalmol, 137, 486, 10.1016/j.ajo.2003.11.069 Augood, 2006, Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE), Arch Ophthalmol, 124, 529, 10.1001/archopht.124.4.529 Owen, 2003, How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?, Br J Ophthalmol, 87, 312, 10.1136/bjo.87.3.312 Brown, 1996, Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome, Ophthalmology, 103, 1100, 10.1016/S0161-6420(96)30561-7 Kedhar, 2007, Multifocal choroiditis with panuveitis and punctate inner choroidopathy: comparison of clinical characteristics at presentation, Retina, 27, 1174, 10.1097/IAE.0b013e318068de72 Thorne, 2006, Multifocal choroiditis with panuveitis incidence of ocular complications and of loss of visual acuity, Ophthalmology, 113, 2310, 10.1016/j.ophtha.2006.05.067 Laatikainen, 1982, Subretinal and disc neovascularisation in serpiginous choroiditis, Br J Ophthalmol, 66, 326, 10.1136/bjo.66.5.326 Jampol, 1979, Subretinal neovascularization with geographic (serpiginous) choroiditis, Am J Ophthalmol, 88, 683, 10.1016/0002-9394(79)90665-2 Gupta, 2008, Posterior sympathetic ophthalmia: a single centre long-term study of 40 patients from North India, Eye (Lond), 22, 1459, 10.1038/sj.eye.6702927 Borkowski, 2001, Laser photocoagulation for choroidal neovascularization associated with sympathetic ophthalmia, Am J Ophthalmol, 132, 585, 10.1016/S0002-9394(01)01044-3 Bernasconi, 1998, Indocyanine green angiographic findings in sympathetic ophthalmia, Graefes Arch Clin Exp Ophthalmol, 236, 635, 10.1007/s004170050134 Chang, 2008, Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration, Arch Ophthalmol, 126, 941, 10.1001/archopht.126.7.941 Miller, 2006, Vision loss in younger patients: a review of choroidal neovascularization, Optom Vis Sci, 83, 316, 10.1097/01.opx.0000216019.88256.eb Spaide, 1999, Choroidal neovascularization in younger patients, Curr Opin Ophthalmol, 10, 177, 10.1097/00055735-199906000-00005 Gaynon, 1984, Retinal neovascularization and ocular toxoplasmosis, Am J Ophthalmol, 98, 585, 10.1016/0002-9394(84)90244-7 Fine, 1981, Choroidal neovascularization as a late complication of ocular toxoplasmosis, Am J Ophthalmol, 91, 318, 10.1016/0002-9394(81)90283-X Xu, 2009, Para-inflammation in the aging retina, Prog Retin Eye Res, 28, 348, 10.1016/j.preteyeres.2009.06.001 Ferrara, 2004, Vascular endothelial growth factor: basic science and clinical progress, Endocr Rev, 25, 581, 10.1210/er.2003-0027 Szekanecz, 2008, Targeting angiogenesis in rheumatoid arthritis, Curr Rheumatol Rev, 4, 298, 10.2174/157339708786263942 Szekanecz, 2010, New insights in synovial angiogenesis, Joint Bone Spine, 77, 13, 10.1016/j.jbspin.2009.05.011 Dirkx, 2006, Monocyte/macrophage infiltration in tumors: modulators of angiogenesis, J Leukoc Biol, 80, 1183, 10.1189/jlb.0905495 Caspi, 1994, Experimental autoimmune uveoretinitis—rat and mouse, 57 Caspi, 1990, The mouse as a model of experimental autoimmune uveoretinitis (EAU), Curr Eye Res, 9, 169, 10.3109/02713689008999438 Forrester, 1990, Comparison of clinical and experimental uveitis, Curr Eye Res, 9, 75, 10.3109/02713689008999424 Forrester, 1992, Experimental autoimmune uveoretinitis: a model system for immunointervention: a review, Curr Eye Res, 11, 33, 10.3109/02713689208999509 Forrester, 2010, Dendritic cell physiology and function in the eye, Immunol Rev, 234, 282, 10.1111/j.0105-2896.2009.00873.x Caspi, 1992, Immunogenetic aspects of clinical and experimental uveitis, Reg Immunol, 4, 321 Dick, 2000, Immune mechanisms of uveitis: insights into disease pathogenesis and treatment, Int Ophthalmol Clin, 40, 1, 10.1097/00004397-200004000-00003 Kerr, 2008, Analysis of retinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations, J Autoimmun, 31, 354, 10.1016/j.jaut.2008.08.006 Copland, 2008, The clinical time-course of experimental autoimmune uveoretinitis using topical endoscopic fundal imaging with histologic and cellular infiltrate correlation, Invest Ophthalmol Vis Sci, 49, 5458, 10.1167/iovs.08-2348 Chen, 2010, Inhibition of the alternative pathway of complement activation reduces inflammation in experimental autoimmune uveoretinitis, Eur J Immunol, 40, 2870, 10.1002/eji.201040323 Lawler, 1998, Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia, J Clin Invest, 101, 982, 10.1172/JCI1684 Xu, 2005, Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood–retina barrier, Invest Ophthalmol Vis Sci, 46, 2487, 10.1167/iovs.04-1333 Xu, 2005, Differentiation to the CCR2+ inflammatory phenotype in vivo is a constitutive, J Immunol, 175, 6915, 10.4049/jimmunol.175.10.6915 Avichezer, 2000, Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype, Invest Ophthalmol Vis Sci, 41, 127 Xu, 2008, A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images, Exp Eye Res, 87, 319, 10.1016/j.exer.2008.06.012 Xu, 2002, Improved leukocyte tracking in mouse retinal and choroidal circulation, Exp Eye Res, 74, 403, 10.1006/exer.2001.1134 Dick, 1994, Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens, Eye, 8, 52, 10.1038/eye.1994.10 Xu, 2007, Identification of novel dendritic cell populations in normal mouse retina, Invest Ophthalmol Vis Sci, 48, 1701, 10.1167/iovs.06-0697 Xu, 2003, Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood–retinal barrier and upregulation of cellular adhesion molecules, Invest Ophthalmol Vis Sci, 44, 226, 10.1167/iovs.01-1202 Ishida, 2003, VEGF164-mediated inflammation is required for pathological, but not physiological, ischemia-induced retinal neovascularization, J Exp Med, 198, 483, 10.1084/jem.20022027 Salcedo, 2000, Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression, Blood, 96, 34, 10.1182/blood.V96.1.34 Byfield, 2004, Lateral signaling enhances TGF-beta response complexity, Trends Cell Biol, 14, 107, 10.1016/j.tcb.2004.01.001 Zamiri, 2005, Thrombospondin plays a vital role in the immune privilege of the eye, Invest Ophthalmol Vis Sci, 46, 908, 10.1167/iovs.04-0362 Tsou, 2001, Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine, J Biol Chem, 276, 44622, 10.1074/jbc.M107327200 Dagkalis, 2009, Development of experimental autoimmune uveitis: efficient recruitment of monocytes is independent of CCR2, Invest Ophthalmol Vis Sci, 50, 4288, 10.1167/iovs.09-3434 Sonoda, 2011, Neutrophil-dominant experimental autoimmune uveitis in CC-chemokine receptor 2 knockout mice, Acta Ophthalmol, 89, e180, 10.1111/j.1755-3768.2010.01953.x Luger, 2008, Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category, J Exp Med, 205, 799, 10.1084/jem.20071258 Amadi-Obi, 2007, TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STAT1, Nat Med, 13, 711, 10.1038/nm1585 Torrado, 2010, IL-17 and Th17 cells in tuberculosis, Cytokine Growth Factor Rev, 21, 455, 10.1016/j.cytogfr.2010.10.004 Toh, 2010, Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition, Ann Rheum Dis, 69, 1562, 10.1136/ard.2009.111757 Toh, 2010, Role of interleukin 17 in arthritis chronicity through survival of synoviocytes via regulation of synoviolin expression, PLoS One, 5, e13416, 10.1371/journal.pone.0013416 McBee, 2010, Multivariate modeling identifies neutrophil- and Th17-related factors as differential serum biomarkers of chronic murine colitis, PLoS One, 5, e13277, 10.1371/journal.pone.0013277 Gordon, 2003, Alternative activation of macrophages, Nat Rev Immunol, 3, 23, 10.1038/nri978 Hesse, 2001, Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of l-arginine metabolism, J Immunol, 167, 6533, 10.4049/jimmunol.167.11.6533 Honey, 2003, Lysosomal cysteine proteases regulate antigen presentation, Nat Rev Immunol, 3, 472, 10.1038/nri1110 Boring, 1997, Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice, J Clin Invest, 100, 2552, 10.1172/JCI119798 Lu, 1998, Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1–deficient mice, J Exp Med, 187, 601, 10.1084/jem.187.4.601 Xiong, 1998, Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway, Am J Pathol, 153, 587, 10.1016/S0002-9440(10)65601-5 Wu, 2010, IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia, Immunobiology, 215, 796, 10.1016/j.imbio.2010.05.025 Friedlander, 2007, Fibrosis and diseases of the eye, J Clin Invest, 117, 576, 10.1172/JCI31030 Forrester, 2008, Immune privilege or privileged immunity?, Mucosal Immunol, 1, 372, 10.1038/mi.2008.27 Ferrari, 2009, Transforming growth factor-beta 1 (TGF-beta1) induces angiogenesis through vascular endothelial growth factor (VEGF)-mediated apoptosis, J Cell Physiol, 219, 449, 10.1002/jcp.21706 Lux, 2006, ALK1 signalling analysis identifies angiogenesis related genes and reveals disparity between TGF-beta and constitutively active receptor induced gene expression, BMC Cardiovasc Disord, 6, 13, 10.1186/1471-2261-6-13